Professor John Prins is an active clinician-scientist, a key opinion leader in diabetes and endocrinology in Australia and sits on numerous national and international scientific, clinical and educational committees and boards for the National Health and Medical Research Council (NHMRC), non-government organisations and industry.
John undertook his clinical training in endocrinology in Brisbane and then completed a PhD in adipose tissue biology at the University of Queensland (UQ).
His first post-doctoral research appointment was at the University of Cambridge, UK, based at Addenbrooke's Hospital. He returned to Brisbane in 1998 after being awarded a Welcome International Senior Research Fellowship.
In 2004 he was Founder/Director of the UQ Centre for Diabetes and Endocrine Research, one of the most prominent and successful groups on the Princess Alexandra Hospital campus, which merged with the UQ Centre for Immunology and Cancer Research (CICR) in January 2007 to form the Diamantina Institute.
As Chair of the Centre of Health Research on the Princess Alexandra Hospital campus from 2005 to 2009, his role involved coordinating the campus-wide research strategy, fostering research, facilitating the recruitment of researchers to the campus and integration of research and clinical activities.
In 2009 John was appointed CEO/Director of the Mater Medical Research Institute.
John has substantial commercialisation experience, holds two international patents and was founder and scientific director of a spin-out biotech company-Adipogen Pty Ltd.
John is actively involved in undergraduate and post-graduate teaching and training and has ongoing research interests in obesity and diabetes.